Tag results:

schizophrenia

Glyoxalase I Disruption and External Carbonyl Stress Impair Mitochondrial Function in Human Induced Pluripotent Stem Cells and Derived Neurons

[Translational Psychiatry] Scientists found that disruption of glyoxalase I , the gene encoding a major catabolic enzyme scavenging the carbonyl group, increased vulnerability to external carbonyl stress, leading to abnormal phenotypes in hiPSCs.

Glutamate and Microglia Activation as a Driver of Dendritic Apoptosis: A Core Pathophysiological Mechanism to Understand Schizophrenia

[Translational Psychiatry] The apoptotic loss of dendritic spines would be aggravated by microglia activation through a recently described signaling system from complement abnormalities and proteins of the MHC, thus implicating the immune system in schizophrenia.

Therapeutic Solutions International Subsidiary Campbell Neurosciences Reports Positive Preclinical Data in Animal Model of Schizophrenia Using Proprietary Universal Donor Mesenchymal Stem Cell

[Therapeutic Solutions International, Inc. (Cision US, Inc.)] Therapeutic Solutions International, Inc. and its subsidiary Campbell Neurosciences announced new data covered by its previously filed patents supporting the use of mesenchymal based stem cell therapy for schizophrenia.

$8M Grant Aims to Better Understand Disease Mechanisms of Schizophrenia

[Mirage News] A research team from the Duke Center for Genomic and Computational Biology have teamed up with scientists at UNC-Chapel Hill and Flora Vaccarino at Yale University to narrow down areas of the genome previously marked relevant to schizophrenia risk.

Vitamin B6 Deficiency Hyperactivates the Noradrenergic System, Leading to Social Deficits and Cognitive Impairment

[Translational Psychiatry] Inhibiting the excessive noradrenaline release by treatment with vitamin B6 supplementation into the brain and α2A adrenoreceptor agonist guanfacine (GFC) suppressed the increased NA metabolism and ameliorated the behavioral deficits.

Disruption of the Blood−Brain Barrier in 22q11.2 Deletion Syndrome

[Brain] Researchers investigated whether the neuroimmune dysregulation vascular phenotype was intrinsically compromised in the most common genetic risk factor for schizophrenia, the 22q11.2 deletion syndrome.

Popular